SCHEMBL5500396

SCHEMBL5500396

Cc1[c]cc(C)c(-c2c(C)cc(C)cc2C)c1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.31
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168421 0.75 MAPT (0.38) RAPGEF4
SCHEMBL3410831 0.72 ALDH1A1 (0.37) RAPGEF4
SCHEMBL5500392 0.70 RAPGEF4 (0.31) RAPGEF4
SCHEMBL225914 0.69 RAPGEF4 (0.38) RAPGEF4PDK2
SCHEMBL2944478 0.68 ESR2 (0.42)
SCHEMBL20553843 0.68 RAPGEF4 (0.34) RAPGEF4PDK2
SCHEMBL162868 0.68
SCHEMBL17514794 0.67
SCHEMBL317299 0.66 RAPGEF4 (0.50) RAPGEF4
SCHEMBL28713658 0.65 RAPGEF4 (0.43) RAPGEF4PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817294-A1 1,2,3,4-TETRAHYDROPYRAZIN-2-YL ACETAMIDES AND THEIR USE AS BRADYKININ ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION RELATED DISORDERS Amgen Inc. (US) 2007-08-15 EP disclosed
WO-2006019975-A1 1,2,3,4-TETRAHYDROPYRAZIN-2-YL ACETAMIDES AND THEIR USE AS BRADYKININ ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION RELATED DISORDERS AMGEN INC. (US) 2006-02-23 WO disclosed